Abstract
This chapter places the development of adverse outcome pathways (AOPs) in their social context. It begins by highlighting the intense social and political polarization that currently exists around environmental regulations. Given this context, any gaps, assumptions, or uncertainties associated with AOPs are likely to receive intense scrutiny whenever they have regulatory implications that could generate adverse consequences for particular stakeholder groups. Therefore, the chapter argues that in the near future, AOPs are likely to be much more fruitful when they are employed in “win-win” contexts, such as in the design of safer chemicals or the assessment of alternative products and methods. Moreover, AOPs are likely to be more useful and more widely accepted if their development process is characterized by two principles: engagement and transparency. Following these principles has the potential to alleviate some of the conflict that has characterized recent chemical regulatory policy.
References
Alberts B, Cicerone R, Fienberg S, Kamb A, McNutt M, Nerem R, Schekman R et al (2015) Self-correction in science at work. Science 348:1420–1422
Animal Rights and Wrongs (2011) Animal Rights and Wrongs. Nature 470(7335):435
Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK et al (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730–741
Becker RA, Ankley GT, Edwards SW, Kennedy SW, Linkov I, Meek B, Sachana M, Segner H, Van Der Burg B, Villeneuve DL, Watanabe H, Barton-McLaren TS (2015) Increasing scientific confidence in adverse outcome pathways: application of tailored Bradford-Hill considerations for evaluating weight of evidence. Regul Toxicol Pharmacol 72:514–537
Beder S (2000) Global spin, revised edn. Chelsea Green, White River Junction
Busenberg G (1999) Collaborative and adversarial analysis in environmental policy. Pol Stud 32:1–11
Colvin V (2003) The potential environmental impact of engineered nanoparticles. Nat Biotechnol 21:1166–1170
Cranor C (2011) Legally poisoned: how the law puts us at risk from toxicants. Oxford University Press, New York
Douglas H (2004) The irreducible complexity of objectivity. Synthese 138:453–473
Douglas H (2005) Inserting the public into science. In: Maasen S, Weingart P (eds) Democratization of expertise? Exploring novel forms of scientific advice in political decision making. Springer, Berlin, pp 153–169
Dwyer M, Stave K (2008) Group model building wins: the results of a comparative analysis. In: Proceedings of the 26th international conference of the system dynamics society, Athens, Greece
Elliott K (2009) Respect for lay perceptions of risk in the hormesis case. Hum Exp Toxicol 28:21–26
Elliott K (2011) Is a little pollution good for you? Incorporating societal values in environmental research. Oxford University Press, New York
Elliott K (2016) Environment. In: Angulo AJ (ed) Miseducation: a history of ignorance making in America and abroad. Johns Hopkins University Press, Baltimore, pp 96–119
Elliott K (2017) A tapestry of values: an introduction to values in science. Oxford University Press, New York
Elliott K, Resnik D (2014) Science, policy, and the transparency of values. Environ Health Perspect 122:647–650
Elliott K, Resnik D (2015) Scientific reproducibility, human error, and public policy. Bioscience 65:5–6
Fiorino D (1990) Citizen participation and environmental risk: a survey of institutional mechanisms. Sci Technol Hum Values 15:226–243
Forbes V, Calow P (2012) Promises and problems for the new paradigm for risk assessment and an alternative approach involving predictive systems models. Environ Toxicol Chem 31:2663–2671
Funtowicz S, Ravetz J (1992) Three types of risk assessment and the emergence of post-normal science. In: Krimsky S, Golding D (eds) Social theories of risk. Praeger, Westport, pp 251–274
Garcia-Reyero N (2015) Are adverse outcome pathways here to stay? Environ Sci Technol 49:3–9
Greek R, Menache A (2013) Systematic reviews of animal models: methodology versus epistemology. Int J Med Sci 10(3):206–221
Groh K, Carvalho R, Chipman J, Denslow N, Halder M, Murphy C, Roelofs D, Rolaki A, Schirmer K, Watanabe K (2014) Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: II. A focus on growth impairment in fish. Chemosphere 120:778–792
Guston D (2008) Innovation policy: not just a jumbo shrimp. Nature 454:940–941
Guston D (2014) Building the capacity for public engagement with science in the United States. Public Underst Sci 23:53–59
Hackett E, Amsterdamska O, Lynch M, Wajcman J (eds) (2007) The handbook of science and technology studies. MIT Press, Cambridge, MA
Hartung T (2013) Look back in anger – what clinical studies tell us about preclinical work. ALTEX 30(3):275–291
Hill AB (1965) The environmental and diseases: association or causation? Proc R Soc Med 58:295–300
Huang R, Xia M, Sakamuru S, Zhao J, Shahane SA, Attene-Ramos M, Zhao T, Austin CP, Simeonov A (2016) Modelling the Tox21 10K chemical profiles for in vivo toxicity prediction and mechanism characterization. Nat Commun 7:10425
Kleinman D, Suryanarayanan S (2015) Ignorance and industry: agrichemicals and honey bee deaths. In: Gross M, McGoey L (eds) Routledge international handbook of ignorance studies. Routledge, New York
Krimsky S (2003) Science in the private interest. Rowman and Littlefield, Lanham
Longino H (2002) The fate of knowledge. Princeton University Press, Princeton
Markowitz G, Rosner D (2002) Deceit and denial: the deadly politics of industrial pollution. University of California Press, Berkeley
McDonough W, Braungart M (2002) Cradle to cradle: remaking the way we make things. North Point Press, New York
Michaels D (2008) Doubt is their product: how Industry’s assault on science threatens your health. Oxford University Press, New York
Myers JP, vom Saal F, Akingbemi B, Arizono K, Belcher S, Colborn T et al (2009) Why public health agencies cannot depend upon good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ Health Perspect 117:309–315
Nosek B, Alter G, Banks C, Borsboom D, Bowman S, Breckler S, Buck S et al (2015) Promoting an open research culture. Science 348:1422–1425
NRC (National Research Council) (1996) Understanding risk: informing decisions in a democratic society. National Academies Press, Washington, DC
NRC (National Research Council) (2007) Toxicity testing in the 21st century: a vision and a strategy. National Academies Press, Washington, DC
OECD Guidance document on developing and assessing adverse outcome pathways (2013) In: Series on testing and assessment, Paris ENV/JM/MONO(2013)6, Paris no. 184, p 145
Oreskes N, Conway E (2010) Merchants of doubt: how a handful of scientists obscured the truth on issues from tobacco smoke to global warming. Bloomsbury Press, New York
Perkins, E., P. Antczak, L. Burgoon, F. Falciani, N. Garcia-Reyero, S. Gutsell, G. Hodges, et al. 2015. Adverse Outcome Pathways for Regulatory Applications: Examination of Four Case Studies with Different Degrees of Completeness and Scientific Confidence. Toxicological Sciences 148:14–25
Pew Initiative on Food and Biotechnology (2002) Three years later: genetically engineered corn and the Monarch butterfly controversy. Available at: http://www.pewtrusts.org/uploadedFiles/wwwpewtrustsorg/Reports/Food_and_Biotechnology/vf_biotech_monarch.pdf. Accessed 26 July 2013
Royal Society (1985) The public understanding of science. Royal Society, London
Sarewitz D (2004) How science makes environmental controversies worse. Environ Sci Policy 7:385–403
Shrader-Frechette K (1995) Evaluating the expertise of experts. Risk: Health, Safety & Environment 6:115–126
Song L, Bagley K (2015) EDF sparks mistrust, and admiration, with its methane research. InsideClimate News (April 8): https://insideclimatenews.org/news/07042015/edf-sparks-mistrust-and-admiration-its-methane-leaks-researchnatural-gas-fracking-climate-change
Soranno P, Cheruvelil K, Elliott K, Montgomery G (2015) It’s good to share: why environmental scientists’ ethics are out of date. Bioscience 65:69–73
Stave KA (2002) Using system dynamics to improve public participation in environmental decisions. Syst Dyn Rev 18(2):139–167
Sterman JD (1994) Learning in and about complex systems. Syst Dyn Rev 10(2,3):291–330
Tickner J (1999) A map toward precautionary decision making. In: Raffensperger C, Tickner J (eds) Protecting public health and the environment: implementing the precautionary principle. Island Press, Washington, DC, pp 162–186
Tickner J (ed) (2003) Precaution, environmental science, and preventive public policy. Island Press, Washington, DC
Tyl R (2009) Basic exploratory research versus guideline-compliant studies used for hazard evaluation and risk assessment: bisphenol a as a case study. Environ Health Perspect 117:1644–1651
Vandenburg LN, Prins GS (2016) Clarity in the face of confusion: new studies tip the scales on Bisphenol A (BPA). Andrology. doi:10.1111/andr.12219
Volz D, Elliott K (2012) Mitigating conflicts of interest in chemical safety testing. Environ Sci Technol 46:7937–7938
Wynne B (1989) Sheep farming after Chernobyl. Environment 31:10–39
Wynne B (2005) Risk as globalizing ‘democratic’ discourse? Framing subjects and citizens. In: Leach M, Scoones I, Wynne B (eds) Science and citizens: globalization and the challenge of engagement. Zed Books, London, pp 66–82
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Elliott, K.C., Murphy, C.A., Garcia-Reyero, N. (2018). The Future of Adverse Outcome Pathways: Analyzing their Social Context. In: Garcia-Reyero, N., Murphy, C. (eds) A Systems Biology Approach to Advancing Adverse Outcome Pathways for Risk Assessment. Springer, Cham. https://doi.org/10.1007/978-3-319-66084-4_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-66084-4_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-66082-0
Online ISBN: 978-3-319-66084-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)